Targeted Therapy With Rituximab, Lenalidomide, and Ibrutinib for DLBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma
J. Clin. Oncol 2022 Aug 11;[EPub Ahead of Print], J Westin, RE Davis, L Feng, F Hagemeister, R Steiner, HJ Lee, L Fayad, L Nastoupil, S Ahmed, A Rodriguez, M Fanale, F Samaniego, SP Iyer, R Nair, Y Oki, N Fowler, M Wang, MCJ Ma, F Vega, T McDonnell, C Pinnix, D Griffith, Y Lu, S Tewari, R Sun, DW Scott, CR Flowers, S Neelapu, MR GreenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.